Tocqueville Asset Management’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-60,000
Closed -$761K 1034
2014
Q3
$761K Buy
60,000
+5,000
+9% +$74.7K 0.01% 545
2014
Q2
$937K Buy
55,000
+3,000
+6% +$44.7K 0.01% 584
2014
Q1
$700K Sell
52,000
-20,000
-28% -$262K 0.01% 511
2013
Q4
$921K Sell
72,000
-4,100
-5% -$43K 0.01% 463
2013
Q3
$688K Buy
76,100
+13,000
+21% +$108K 0.01% 571
2013
Q2
$454K Buy
+63,100
New +$463K 0.01% 661

Tocqueville Asset Management's DRTX Position: Q4 2014 in Review

Tocqueville Asset Management sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 60,000 shares — an estimated $761K sold.

Tocqueville Asset Management first reported a position in DRTX in Q2 2013 and held it in 6 quarters. The position peaked at $937K in Q2 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

  • Tocqueville Asset Management reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • Tocqueville Asset Management sold 60,000 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $761K.
  • Tocqueville Asset Management first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
  • Tocqueville Asset Management's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $937K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on Tocqueville Asset Management's 13F filing for Q4 2014, filed 30 Jan 2015.